What does Ascensia Diabetes Care Belgium do?

Ascensia Diabetes Care Belgium is a wholesaler in Machelen (Brab.). Public Limited, started on 4 September 2015, 1 establishment.

What is the address of Ascensia Diabetes Care Belgium?

The registered office of Ascensia Diabetes Care Belgium is located at De Kleetlaan 5BC, 1831 Machelen (Brab.).

Is Ascensia Diabetes Care Belgium still active?

Yes. According to the CBE (2 November 2026) Ascensia Diabetes Care Belgium is active, legal situation “Normale toestand”, started on 4 September 2015.

Is Ascensia Diabetes Care Belgium registered on Peppol?

Yes, Ascensia Diabetes Care Belgium is registered on the Peppol network with ID 0208:0636787578.

What is the enterprise number of Ascensia Diabetes Care Belgium?

The enterprise number of Ascensia Diabetes Care Belgium is BE0636787578.

When was Ascensia Diabetes Care Belgium founded?

Ascensia Diabetes Care Belgium was founded on 4 September 2015.

Who are the directors of Ascensia Diabetes Care Belgium?

According to the 2026 annual accounts, the directors of Ascensia Diabetes Care Belgium are: Thierry Kalin, Christophe De Rudder.

Is Ascensia Diabetes Care Belgium a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 September 2015; 5 annual accounts filed, latest fiscal year 2026; 2 directors known from the annual account.

How much profit did Ascensia Diabetes Care Belgium make in 2026?

Ascensia Diabetes Care Belgium posted a profit after taxes of € 261,462 in financial year 2026.

What is the revenue of Ascensia Diabetes Care Belgium?

As a small company, Ascensia Diabetes Care Belgium is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 1,536,002.

How much does an employee at Ascensia Diabetes Care Belgium earn?

The average wage cost per full-time employee at Ascensia Diabetes Care Belgium was € 134,600 in 2026: staff costs of € 1.1 million for 8.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Ascensia Diabetes Care Belgium have?

According to the 2026 annual accounts, Ascensia Diabetes Care Belgium has 8.3 full-time equivalents (FTE).

Ascensia Diabetes Care Belgium (Public Limited)

Dossier Ascensia Diabetes Care Belgium, printed on 2 November 2026 from databakkes.be/en/0636787578/ascensia-diabetes-care-belgium. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Board fully replaced NBB

No director from three years ago is still active according to annual account 2026.
Busy address KBO

53 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2026

Ascensia Diabetes Care Belgium from Machelen (Brab.), company number BE0636787578, closed financial year 2026 with a result of € 261,462 after tax. For that financial year Ascensia Diabetes Care Belgium recorded a gross margin of € 1.5 million and equity of € 1.6 million. Compared with financial year 2025, the result moved from € 212,830 to € 261,462. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 22, 2026.

What it is worth Growing

€ 1.6 million

▲ 19% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 261,462

▲ 23% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 1.7 million

▲ 29% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 701,131.

People and assets in 2026

Full-time equivalents

8.3

▲ 0.3 vs 2025

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.1 million

▲ 3% vs 2025

€ 134,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 588,077

▲ 9% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 387,467

▲ 2% vs 2025

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 1,568,120 Gross margin 2023: € 1,568,120 First fiscal year in the series	€ 1,647,964 Gross margin 2024: € 1,647,964 ▲ 5% vs 2023 (€ 1,568,120) Favourable step	€ 1,396,430 Gross margin 2025: € 1,396,430 ▼ 15% vs 2024 (€ 1,647,964) Unfavourable step	€ 1,536,002 Gross margin 2026: € 1,536,002 ▲ 10% vs 2025 (€ 1,396,430) Favourable step	▲ 10%
Profit after taxes	€ 89,664 Profit after taxes 2023: € 89,664 First fiscal year in the series	€ 201,580 Profit after taxes 2024: € 201,580 ▲ 125% vs 2023 (€ 89,664) Favourable step	€ 212,830 Profit after taxes 2025: € 212,830 ▲ 6% vs 2024 (€ 201,580) Favourable step	€ 261,462 Profit after taxes 2026: € 261,462 ▲ 23% vs 2025 (€ 212,830) Favourable step	▲ 23%
Equity	€ 957,165 Equity 2023: € 957,165 First fiscal year in the series	€ 1,158,745 Equity 2024: € 1,158,745 ▲ 21% vs 2023 (€ 957,165) Favourable step	€ 1,371,576 Equity 2025: € 1,371,576 ▲ 18% vs 2024 (€ 1,158,745) Favourable step	€ 1,633,037 Equity 2026: € 1,633,037 ▲ 19% vs 2025 (€ 1,371,576) Favourable step	▲ 19%
Total debts	€ 1,707,799 Total debts 2023: € 1,707,799 First fiscal year in the series	€ 872,525 Total debts 2024: € 872,525 ▼ 49% vs 2023 (€ 1,707,799) Favourable step	€ 919,355 Total debts 2025: € 919,355 ▲ 5% vs 2024 (€ 872,525) Unfavourable step	€ 975,545 Total debts 2026: € 975,545 ▲ 6% vs 2025 (€ 919,355) Unfavourable step	▲ 6%
Cash	€ 1,385,939 Cash 2023: € 1,385,939 First fiscal year in the series	€ 856,270 Cash 2024: € 856,270 ▼ 38% vs 2023 (€ 1,385,939) Unfavourable step	€ 1,338,080 Cash 2025: € 1,338,080 ▲ 56% vs 2024 (€ 856,270) Favourable step	€ 1,729,863 Cash 2026: € 1,729,863 ▲ 29% vs 2025 (€ 1,338,080) Favourable step	▲ 29%
Retained profit	€ 25,259 Retained profit 2023: € 25,259 First fiscal year in the series	€ 226,839 Retained profit 2024: € 226,839 ▲ € 201,580 vs 2023 (€ 25,259) Favourable step	€ 439,670 Retained profit 2025: € 439,670 ▲ 94% vs 2024 (€ 226,839) Favourable step	€ 701,131 Retained profit 2026: € 701,131 ▲ 59% vs 2025 (€ 439,670) Favourable step	▲ 59%
Dividend	€ 479,929 Dividend 2023: € 479,929 First fiscal year in the series	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 479,929) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2026: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 2,664,964 Balance sheet total 2023: € 2,664,964 First fiscal year in the series	€ 2,031,271 Balance sheet total 2024: € 2,031,271 ▼ 24% vs 2023 (€ 2,664,964) Unchanged	€ 2,290,931 Balance sheet total 2025: € 2,290,931 ▲ 13% vs 2024 (€ 2,031,271) Unchanged	€ 2,608,582 Balance sheet total 2026: € 2,608,582 ▲ 14% vs 2025 (€ 2,290,931) Unchanged	▲ 14%
Employees (FTE)	10.3 Employees (FTE) 2023: 10.3 First fiscal year in the series	8.3 Employees (FTE) 2024: 8.3 ▼ 2 vs 2023 (10.3) Unchanged	8 Employees (FTE) 2025: 8 ▼ 0.3 vs 2024 (8.3) Unchanged	8.3 Employees (FTE) 2026: 8.3 ▲ 0.3 vs 2025 (8) Unchanged	▲ 0.3

Key figures of Ascensia Diabetes Care Belgium, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to Ascensia Diabetes Care Belgium?

What happened at Ascensia Diabetes Care Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 22, 2026 New annual accounts for financial year 2026: profit of € 261,462 (▲ 23% vs 2025). Source: NBB ↗
2025 Thierry Kalin became a director. NBB
2025 Christophe De Rudder stepped down as director. NBB
2016 Christophe De Rudder became a director. NBB
Jan 5, 2016 New establishment in Machelen (Brab.). KBO
Sep 4, 2015 Start of the company according to the CBE. KBO

In short

From € 89,664 profit in 2023 to € 261,462 profit in 2026.

Paid € 400,349 in corporate taxes since 2023.

Best year ever: 2026, with € 261,462 profit.

On average € 185,100 of value added per employee in 2026.

Original PDFs at the National Bank ↗

Management

Ascensia Diabetes Care Switzerland AG 0%

Ascensia Diabetes Care Holdings AG 0%

Ascensia Diabetes Care Belgium

Behind Ascensia Diabetes Care Belgium is Thierry Kalin. The shares are held by Ascensia Diabetes Care Switzerland AG (0%) and Ascensia Diabetes Care Holdings AG (0%).

Directors

According to the 2026 annual accounts

Thierry Kalin

Director

since 2025

Christophe De Rudder

Director

since 2016 · until 2025

Shareholders

Ascensia Diabetes Care Switzerland AG

Ascensia Diabetes Care Holdings AG

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

De Kleetlaan 5BC

1831 Machelen (Brab.)

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 53 companies are registered at this address.

All companies at this address →

Seco Tools Benelux

€ 18.5 million revenue · 2025

I.I.A.-BEL, INSTITUUT VAN INTERNE AUDITOREN-BELGIE - INSTITUT DES AUDITEURS INTERNES-BELGIQUE - INSTITUTEOF INTERNAL AUDITORS-BELGIUM

Wipro CRM Services

€ 2 million revenue · 2026

Netapp Belgium

€ 22.7 million revenue · 2025

VANGUARD DECISION

€ 41,102 gross margin · 2025

+48 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0636.787.578

VAT number

BE 0636.787.578

Registered office

De Kleetlaan 5BC, 1831 Machelen (Brab.)

Names & denominations

Ascensia Diabetes Care Belgium

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

4 September 2015

Peppol

Active · Active since 21 Nov 2025

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in andere machines en werktuigen, neg

Groothandel in andere machines en werktuigen, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

Ascensia Diabetes Care Belgium

Warning lights

Financials

What happened to Ascensia Diabetes Care Belgium?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions